Elizabeth Trehu Jounce Therapeutics, Inc. (JNCE) insider trading activity

Elizabeth Trehu is Chief Medical Officer of Jounce Therapeutics, Inc.. Currently has a direct ownership of 103,417 shares of JNCE, which is worth approximately $0. The most recent transaction as insider was on Jan 10, 2023, when has been sold 5,126 shares (Common Stock) at a price of $1.12 per share, resulting in proceeds of $5,741. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 103K

0% 3M change

0% 12M change

Total Value Held $0

Elizabeth Trehu Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2023	SELL Open market or private sale	$5,741 $1.12 p/Share	5,126 Reduced 4.72%	103,417 Common Stock
Jan 09 2023	SELL Open market or private sale	$4,574 $1.1 p/Share	4,159 Reduced 3.69%	108,543 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	27,500 Added 19.61%	112,702 Common Stock
Jan 10 2022	SELL Open market or private sale	$35,764 $6.65 p/Share	5,378 Reduced 5.94%	85,202 Common Stock
Jan 07 2022	SELL Open market or private sale	$21,937 $7.3 p/Share	3,005 Reduced 3.21%	90,580 Common Stock
Mar 31 2021	SELL Open market or private sale	$83,747 $10.09 p/Share	8,300 Reduced 8.15%	93,585 Common Stock
Mar 31 2021	BUY Exercise of conversion of derivative security	$33,366 $4.02 p/Share	8,300 Added 7.53%	101,885 Common Stock
Mar 30 2021	SELL Open market or private sale	$1,000 $10.0 p/Share	100 Reduced 0.11%	93,585 Common Stock
Mar 30 2021	BUY Exercise of conversion of derivative security	$402 $4.02 p/Share	100 Added 0.11%	93,685 Common Stock
Mar 29 2021	SELL Open market or private sale	$51,459 $10.09 p/Share	5,100 Reduced 5.17%	93,585 Common Stock
Mar 29 2021	BUY Exercise of conversion of derivative security	$20,502 $4.02 p/Share	5,100 Added 4.91%	98,685 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	-	22,250 Added 19.21%	93,585 Common Stock
Jan 20 2021	SELL Open market or private sale	$78,065 $12.01 p/Share	6,500 Reduced 8.35%	71,335 Common Stock
Jan 20 2021	BUY Exercise of conversion of derivative security	$26,130 $4.02 p/Share	6,500 Added 7.71%	77,835 Common Stock
Jan 08 2021	SELL Open market or private sale	$19,922 $7.0 p/Share	2,846 Reduced 3.84%	71,335 Common Stock
Jan 07 2021	SELL Open market or private sale	$16,576 $6.76 p/Share	2,452 Reduced 3.2%	74,181 Common Stock

Also insider at

CNST

CONSTELLATION PHARMACEUTICALS INC Healthcare

Elizabeth Trehu

Chief Medical Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNCE shares.

Notify only if

Value

Insider Trading

Get notified when an Jounce Therapeutics, Inc. insider buys or sells JNCE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jounce Therapeutics, Inc.

Track Activities on JNCE

Account